Autoimmune

Filgotinib shows consistent efficacy in rheumatoid arthritis, regardless of BMI changes

The rheumatoid arthritis (RA) medication filgotinib demonstrated consistent efficacy across various body mass index (BMI) ranges, according to a study that found that changes in BMI were minimal for most patients, and these variations did not significantly impact the effectiveness of filgotinib. However, it was noted that with higher doses...